Search

everythinglearnresearchcommunity

for

Search:↓

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Axitinib treatment turned a man's grey hair back to black.

5-alpha-reductase inhibitors can effectively treat benign prostatic hyperplasia.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

The inhibitor affects androgen metabolism but not ovarian function.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Finasteride improves heart function and repairs damage after heart attack in mice.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Upadacitinib may effectively treat alopecia areata without side effects.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

5-ARI therapy may help prevent prostate cancer progression.

Long-term use of a certain medication can worsen erectile function in aged rats by damaging penile muscle cells.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Stopping captopril resolved the skin and hair issues, suggesting it caused them.

Tamsulosin with Serenoa repens is as effective as with 5-alpha-reductase inhibitors but causes fewer side effects.

Isoginkgetin reduces inflammation in cells by blocking NF-κB activation.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Ritlecitinib is safe and may effectively treat alopecia areata.

Combining 5α-reductase and aromatase inhibitors may better reduce estrogen levels.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.